ArticleInternational cancer conference journal2025
Adjuvant radiotherapy for papillary tumor of the pineal region: a case report with a narrative review of the literature.
Article in International cancer conference journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Papillary tumors of the pineal region (PTPR) are rare neoplasms arising from pineal gland and occurring in less than 1% of adult patients. Surgery is reported as the main treatment option, although the role of radiotherapy, especially in the adjuvant setting, remains controversial. A young adult woman of 24 years received adjuvant radiotherapy after a subtotal resection of a PTPR. The patient was treated with helical tomotherapy for a total dose of 59.4 Gy delivered in 33 fractions with no concurrent chemotherapy. After initial follow-up MRI exams documented stable disease, later imaging reported a slight decrease in size of the treated lesion. After 2 years of follow-up the patient is in good general conditions, with no evidence of recurrence, and no major side effects from the treatment. This descriptive case highlights the role of adjuvant radiotherapy as a safe and effective treatment option to reduce the risk of local recurrence. Modern radiotherapy techniques may easily allow the delivery of higher doses to the target to reduce the incidence of disease relapse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.